# Observational endometrial cancer studies: 89 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 89 trials that are observational for endometrial cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational endometrial cancer studies: 89 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/endometrial-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 89
- Recruiting or not yet: 89
- Read on: November 19, 2026

## Trials

The 25 newest of 89, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 23, 2026 | NCT07892755 | Liquid Biopsy-Based Early Screening for Endometrial Cancer in Regional Chinese Populations | Guizhou Provincial People's Hospital | Observational | Recruiting | Endometrial Cancer, Atypical Endometrial Hyperplasia | 512 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07892755) |
| October 20, 2026 | NCT07883798 | Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions | Affidea Nu-med Center of Oncological DIagnostics and Therapy | Observational | Recruiting | Cervical Cancer, Gynecologic Cancer, Endometrial Cancer, Uterine Cancer, Uterine Sarcoma, Ovarian Cancer, Fallopian... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883798) |
| October 16, 2026 | NCT07877779 | Protocol for Non-invasive Gynaecological Surveillance in Lynch Syndrome | University of Edinburgh | Observational | Not yet recruiting | Lynch Syndrome | 1,450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07877779) |
| September 24, 2026 | NCT07838207 | Prognosis and Therapeutic Implications in Molecular High-Risk Non-Myoinvasive Endometrial Cancer | Hospital Universitari Vall d'Hebron Research Institute | Observational | Recruiting | Endometrial Cancer, Endometrial Carcinoma (EC), p53abn | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07838207) |
| September 11, 2026 | NCT07814872 | A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment | Harvard Medical School (HMS and HSDM) | Observational | Not yet recruiting | Neoplasms (Cancer / Tumors), Colorectal Neoplasms, Lung Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Pancreatic... | 30,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07814872) |
| September 8, 2026 | NCT07808164 | ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort | Tam Anh Research Institute | Observational | Recruiting | HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer), Gastric Carcinoma, Breast Cancer, Lung Cancer, Endometrial... | 162 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07808164) |
| July 14, 2026 | NCT07702721 | Intraoperative Microscopic Assessment of Lymph Node Status in Gynecological Malignancies | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Gynecologic Cancer, Cervical Cancer, Endometrial Cancer, Ovary Cancer, Vulvar Cancer | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07702721) |
| May 13, 2026 | NCT07583329 | Comparison of Sentinel Lymph Node Applications in Endometrial Cancer Cases Performed With Vaginal Natural Orifice Transluminal Endoscopic... | Cukurova University | Observational | Not yet recruiting | Endometrial Adenocarcinoma, Endometrial Cancer | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07583329) |
| May 12, 2026 | NCT07581288 | Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression | University of British Columbia | Observational | Not yet recruiting | Uterine Bleeding, Uterine Cancer, Uterine Neoplasms, Endometrial Cancer, Endometrial Hyperplasia, Endometrial... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07581288) |
| April 30, 2026 | NCT07558889 | The Surveillance, Epidemiology, and End Results Database Program on Endometrial Cancer in the Italian Population | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Recruiting | Endometrium Cancer, Gynecologic Cancer | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07558889) |
| April 29, 2026 | NCT07555665 | REal Word aPpLicAtion of Molecular Based Endometrial Cancer Classification | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Recruiting | Endometrial Cancer | 264 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07555665) |
| April 14, 2026 | NCT07527143 | Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer | Mayo Clinic | Observational | Recruiting | Endometrial Carcinoma | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07527143) |
| February 27, 2026 | NCT07435623 | Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study | Tata Memorial Hospital | Observational | Recruiting | Endometrial Cancer, Cervix Cancer | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07435623) |
| February 12, 2026 | NCT07407959 | Screening and Staging of Benign vs Malignant Pelvic Abnormalities | Mayo Clinic | Observational | Recruiting | Endometrial Carcinoma, Prostate Carcinoma | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07407959) |
| February 10, 2026 | NCT07400835 | Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and... | University of Aarhus | Observational | Recruiting | Postmenopausal Bleeding | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07400835) |
| February 9, 2026 | NCT07397624 | Endoscopic Suture Gastroplasty (ESG) for Treatment of Obese Patients With Endometrial Cancer | Centro di Riferimento Oncologico - Aviano | Observational | Recruiting | Endometrial Cancer | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07397624) |
| February 3, 2026 | NCT07382583 | Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention... | M.D. Anderson Cancer Center | Observational | Recruiting | Levonorgestrel, Intrauterine Systems, Prevention, Endometrial Cancer | 270 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07382583) |
| February 2, 2026 | NCT07382505 | Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer | Asan Medical Center | Observational | Not yet recruiting | Uterine Neoplasms, Cervical Cancer | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07382505) |
| February 2, 2026 | NCT07380698 | The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological Cancer | Cukurova University | Observational | Recruiting | Endometrial Cancer, Vulvar Cancers, Cervical Cancer, Indocyanine Green (ICG) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07380698) |
| January 26, 2026 | NCT07368205 | Preoperative Risk Stratification in Endometrial Cancer for Tailoring Lymph Node Staging | University Hospital Hradec Kralove | Observational | Recruiting | Endometrial Cancer | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07368205) |
| January 8, 2026 | NCT07327489 | Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) | Elephas | Observational | Recruiting | Cancer, Immunotherapy, Advanced Solid Tumors Cancer, Bladder Cancer, TNBC, Triple Negative Breast Cancer, Colorectal... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07327489) |
| December 23, 2025 | NCT07298707 | Cervical Cytology DNA Methylation for Endometrial Lesion Screening and Follow-up | Peking Union Medical College Hospital | Observational | Not yet recruiting | Endometrial Neoplasms, DNA Methylation, Cervical Smears, Early Detection of Cancer, Endometrial Hyperplasia | 3,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07298707) |
| December 5, 2025 | NCT07267780 | Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases. | National Cancer Institute, Naples | Observational | Not yet recruiting | Ovarian Carcinoma, Cervical Carcinoma, Endometrial Carcinoma, Vulvar Carcinoma, Uterine Sarcoma, Gynecologic Tumor | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07267780) |
| December 2, 2025 | NCT07258186 | Generation of Endometrial Carcinoma Organoids | Regina Elena Cancer Institute | Observational | Recruiting | Endometrial Cancer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07258186) |
| October 24, 2025 | NCT07220512 | The Better, Harder, Faster, Stronger Study | Wake Forest University Health Sciences | Observational | Recruiting | Frailty at Older Adults, Ovarian Cancer, Endometrial Cancer, Cognitive Dysfunction, Neoadjuvant Chemotherapy | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07220512) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 9 |
| Mayo Clinic | 6 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 4 |
| National Cancer Institute, Naples | 3 |
| McGill University | 2 |
| Centro di Riferimento Oncologico - Aviano | 2 |
| Asan Medical Center | 2 |
| Cukurova University | 2 |
| University of Aarhus | 2 |
| Far Eastern Memorial Hospital | 2 |
| Regina Elena Cancer Institute | 2 |
| M.D. Anderson Cancer Center | 2 |
| University of British Columbia | 2 |
| Cycle Therapeutics Ltd | 1 |
| Tata Memorial Hospital | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Centre Francois Baclesse | 1 |
| Tam Anh Research Institute | 1 |
| Radboud University Medical Center | 1 |
| Hospital Italiano de Buenos Aires | 1 |
| Region Västerbotten | 1 |
| Adela, Inc | 1 |
| Women's Hospital School Of Medicine Zhejiang University | 1 |
| San Raffaele University | 1 |
| University Hospital Hradec Kralove | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 22 |
| Italy | 20 |
| China | 8 |
| Germany | 6 |
| Canada | 4 |
| Spain | 4 |
| Czechia | 3 |
| South Korea | 3 |
| Turkey (Türkiye) | 3 |
| France | 2 |
| Netherlands | 2 |
| United Kingdom | 2 |
| Denmark | 2 |
| Taiwan | 2 |
| India | 1 |
| Norway | 1 |
| Saudi Arabia | 1 |
| Vietnam | 1 |
| Sweden | 1 |
| Egypt | 1 |
| Puerto Rico | 1 |
| Poland | 1 |
| Russia | 1 |
| Mexico | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Importers in the United States](https://specstream.ai/data/businesses/importers/united-states)
- [Mediterranean restaurants in the United States](https://specstream.ai/data/businesses/mediterranean-restaurants/united-states)
- [Plastics companies in the United States](https://specstream.ai/data/businesses/plastics-companies/united-states)
- [Sign makers in the United States](https://specstream.ai/data/businesses/sign-makers/united-states)
- [Vegan restaurants in the United States](https://specstream.ai/data/businesses/vegan-restaurants/united-states)
- [Automotive companies in the United States](https://specstream.ai/data/businesses/automotive-companies/united-states)
